• $
  • €
  • ₽
  • ₺
  • £

Blood test to spot learning disabilities in babies is approved

Blood test to spot learning disabilities in babies is approved
21.01.2014 18:26
A unique blood test that can help diagnose learning disabilities in babies by analyzing their genetic code has been approved by the Food and Drug Administration.

The lab test is able to detect variations in chromosomes that are linked to Down syndrome, DiGeorge syndrome and other developmental disorders. Known as CytoScan Dx Assay, the test is designed to help doctors diagnose disabilities earlier so children can get appropriate care and support.About 2 to 3 per cent of children in the U.S. have some sort of intellectual disability, according to the National Institutes of Health. While the test from Affymetrix can help spot potential problems earlier, it is not intended for prenatal screening, and can not predict other genetically acquired diseases, such as cancer.While there are already genetic tests used to detect conditions such as Down syndrome, doctors usually have to order them individually and they can take several days to develop. Pediatricians said on Friday that Affymetrix's test should offer a faster, more comprehensive screening approach.  Dr Annemarie Stroustrup stressed that such tests are generally used only after children exhibit certain physical or behavioral signs that suggest a disorder.'When there's something about the child that strikes us as unusual or pointing to a potential genetic disease, that's when we would use this testing,' Dr Stroustrup, an assistant professor of pediatrics at Mount Sinai Hospital in New York, said. 'This is not a screening test to be done on all newborns to predict how they are going to do in school when they are 5.'Hospitals in all 50 states are currently required to screen newborns for at least 29 disorders that can be detected though laboratory testing, including sickle cell anemia and cystic fibrosis. Generally those tests pick up irregularities in metabolism, not genetic variations. The mandatory screening program, begun half a century ago, is considered one of the nation's most successful public health programs.The FDA said it approved the new test based on studies showing it accurately analyzes a patient's entire genome and can accurately spot variations associated with intellectual disabilities.(dailymail.co.uk)ANN.Az

Instagram
Go
Similar news
Similar news
CSTO Secretary General: Armenia Has De Facto Withdrawn from the Organization
Society 09:30
CSTO Secretary General: Armenia Has De Facto Withdrawn from the Organization
Disruptions Hit Official Websites of Azerbaijani State Agencies
Society 18:00
Disruptions Hit Official Websites of Azerbaijani State Agencies
Flu Vaccination Campaign Underway in Baku and Sumgayit with Dutch Vaccine
Society 17:30
Flu Vaccination Campaign Underway in Baku and Sumgayit with Dutch Vaccine
Abortion Rates in Azerbaijan Rise 21.9% in 2025, Statistics Committee Reports
Society 16:29
Abortion Rates in Azerbaijan Rise 21.9% in 2025, Statistics Committee Reports
Cabinet Approves Updated Board of Defense Industry Ministry
Society 15:00
Cabinet Approves Updated Board of Defense Industry Ministry
US and Israel weigh Iran strikes after November 3
Society 09:30
US and Israel weigh Iran strikes after November 3
Azerbaijan Launches Free Seasonal Flu Vaccination Campaign
Society 16:30
Azerbaijan Launches Free Seasonal Flu Vaccination Campaign
Absheron to Build $591M Regional Waste Landfill Under Livable Baku
Society 13:00
Absheron to Build $591M Regional Waste Landfill Under Livable Baku
Youth Cancer Diagnoses Decline in Azerbaijan
Society 17:59
Youth Cancer Diagnoses Decline in Azerbaijan
Anews TV

Our official Youtube channel

Subscribe